Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCharacter Regulatory News (CCT)

Share Price Information for Character (CCT)

Share Price is delayed by 15 minutes
Get Live Data
282.00    0.00 (0.00%)
Bid:
274.00
Ask:
290.00
Spread: 16.00 (5.839%)
Market Cap: £49.13m
CCT Live PriceLast checked at - London Stock Exchange

Intraday Character Share Chart

Trading Statement

24 Mar 2020 17:49

RNS Number : 4592H
Character Group PLC
24 March 2020
 

 

 

 

 

 

The information contained within this announcement is deemed by the Company to constitute inside information

stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via

the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

 

LONDON: Tuesday, 24 March 2020

 

 

THE CHARACTER GROUP PLC

("Group", "Company" or "Character")

Trading Update

 

 

The Character Group (AIM: CCT) the designer, developer and international distributor of branded toys, games and giftware, today provides an update in light of recent developments regarding COVID-19, the issue of governmental guidance, the implementation of mitigation measures and the rapidly changing landscape in its markets.

Character is not immune from the damaging effects of COVID-19. We continue to prioritise the health and safety of all employees and partners.

The Group's supply side operations in the Far East have experienced temporary disruption, however, they have been broadly restored, with most factories now reporting a return to near normal production capabilities. Orders for direct shipments from the Far East to international distributors and customers in the UK (FOB) are being received and processed through the Group's Far East offices. The demand side of the business, particularly in the UK, is being deeply impacted by closures of non-essential stores, shops and warehousing and distribution centres, albeit that some online retailer customers continue to place a modest level of orders.

The Board is anticipating a significant drop in revenue in H2 FY20 compared to current market expectations, which will inevitably impact profitability for FY20 but, without knowing for how long closures will last or how soon usual retail footfall levels will return, it is too early to assess the quantum of this impact.

The Group has a strong balance sheet and is debt-free, with a substantial cash balance and considerable unutilised working capital facilities. The premises from which Character operates in the UK are freehold properties owned by the Group and are, therefore, free from rent liabilities. In addition, the Company has taken measures to reduce costs, wherever it can.

It is now anticipated that the Group's interim results for the six months ended 29 February 2020 will be issued during the last week of May 2020 and, in the absence of any further material developments in the meantime, the Board plans to provide an update at that time.

 

 

 

ENQUIRIES:

 

The Character Group plc

Kiran Shah, Joint Managing Director & Group Finance Director

Jon Diver, Joint Managing Director

Office: +44 (0) 208 329 3377

Email: info@charactergroup.plc.uk

 

Panmure Gordon (Nominated Adviser and Joint Broker)

Atholl Tweedie, Investment Banking

Charles Leigh-Pemberton, Corporate Broking

Tel: +44 (0) 20 7886 2500

 

Allenby Capital Limited (Joint Broker)

Nick Athanas

Tel: +44 (0) 20 3328 5656

 

 

 

TooleyStreet Communications Limited (Investor and media relations)

Fiona Tooley

Tel: +44 (0) 7785 703523

Email: fiona@tooleystreet.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBRGDXUSDDGGS
Date   Source Headline
29th Dec 20251:27 pmRNSTransaction in Own Shares and Total Voting Rights
29th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Dec 20255:33 pmRNSTransaction in Own Shares and Total Voting Rights
19th Dec 20255:33 pmRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20256:06 pmRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20256:06 pmRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20259:56 amRNSTransaction in Own Shares and Total Voting Rights
17th Dec 20257:00 amRNSAnnual Results - financial year end 31 August 2025
15th Dec 20256:18 pmRNSTransaction in Own Shares and Total Voting Rights
9th Dec 20256:20 pmRNSTransaction in Own Shares and Total Voting Rights
4th Dec 20255:59 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Dec 20255:00 pmRNSTransaction in Own Shares and Total Voting Rights
2nd Dec 20255:17 pmRNSTransaction in Own Shares and Total Voting Rights
28th Nov 20254:28 pmRNSTransaction in Own Shares and Total Voting Rights
26th Nov 20256:19 pmRNSTransaction in Own Shares and Total Voting Rights
25th Nov 20255:08 pmRNSTransaction in Own Shares and Total Voting Rights
24th Nov 20255:54 pmRNSTransaction in Own Shares and Total Voting Rights
21st Nov 20253:44 pmRNSTransaction in Own Shares and Total Voting Rights
18th Nov 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Nov 202511:40 amRNSTransaction in Own Shares and Total Voting Rights
10th Nov 20253:54 pmRNSTransaction in Own Shares and Total Voting Rights
6th Nov 20255:54 pmRNSTransaction in Own Shares and Total Voting Rights
4th Nov 20253:03 pmRNSTransaction in Own Shares and Total Voting Rights
4th Nov 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
31st Oct 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights
30th Oct 20256:01 pmRNSTransaction in Own Shares and Total Voting Rights
28th Oct 20254:54 pmRNSTransaction in Own Shares and Total Voting Rights
27th Oct 20252:45 pmRNSTransaction in Own Shares and Total Voting Rights
22nd Oct 20255:38 pmRNSTransaction in Own Shares and Total Voting Rights
21st Oct 20255:37 pmRNSTransaction in Own Shares and Total Voting Rights
20th Oct 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Oct 20256:20 pmRNSTransaction in Own Shares and Total Voting Rights
14th Oct 20256:14 pmRNSTransaction in Own Shares and Total Voting Rights
13th Oct 20255:45 pmRNSTransaction in Own Shares and Total Voting Rights
8th Oct 20255:07 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Oct 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Oct 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Oct 20257:00 amRNSTrading Update & NED Appointment
30th Sep 20256:02 pmRNSTransaction in Own Shares and Total Voting Rights
29th Sep 20255:54 pmRNSTransaction in Own Shares & Total Voting Rights
23rd Sep 20255:01 pmRNSTransaction in Own Shares & Total Voting Rights
16th Sep 20255:46 pmRNSTransaction in Own Shares & Total Voting Rights
15th Sep 20255:42 pmRNSTransaction in Own Shares & Total Voting Rights
12th Sep 20254:00 pmRNSTransaction in Own Shares & Total Voting Rights
11th Sep 20255:13 pmRNSTransaction in Own Shares & Total Voting Rights
11th Sep 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
9th Sep 20255:13 pmRNSTransaction in Own Shares & Total Voting Rights
5th Sep 20252:40 pmRNSTransaction in Own Shares & Total Voting Rights
3rd Sep 20254:30 pmRNSTransaction in Own Shares & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.